Telomir Pharmaceuticals, Inc. (NASDAQ:TELO), a clinical-stage biotechnology company developing small

MIAMI, Oct. 06, 2026 (GLOBE NEWSWIRE) -- Telomir Pharmaceuticals, Inc. (NASDAQ: TELO), a clinical-st

In matched Cleveland Clinic and Jewish General Hospital samples, blood-based TELO enumeration detect

Gainers DataMEDS AI (NASDAQ:MEDS) shares increased by 12.9% to $4.24 during Friday's after-mark

Gainers Alaunos Therapeutics (NASDAQ:TCRT) shares moved upwards by 30.0% to $2.08 during Thursday&#

Maxim Group analyst Jason McCarthy initiates coverage on Telomir Pharmaceuticals (NASDAQ:TELO) wi

MIAMI, Sept. 17, 2026 (GLOBE NEWSWIRE) -- Telomir Pharmaceuticals, Inc. (NASDAQ: TELO), a clinical-s

Telomir Pharmaceuticals, Inc. (NASDAQ:TELO), a clinical-stage biotechnology company developing small

MIAMI, Sept. 14, 2026 (GLOBE NEWSWIRE) -- Telomir Pharmaceuticals, Inc. (NASDAQ:TELO), a clinical-st

Shares of Telomir Pharmaceuticals, Inc. (NASDAQ: TELO - Get Free Report) were down 3.4% during mid-d

Gainers Bluejay Diagnostics (NASDAQ:BJDX) stock moved upwards by 42.0% to $1.42 during Tuesday'

Gainers China Pharma Holding (AMEX:CPHI) shares increased by 713.2% to $7.4 during Tuesday's re

Gainers iTonic Holdings (NASDAQ:ITOC) stock increased by 8.1% to $0.3 during Friday's after-mar

Insulin Resistance Was Normalized Following 14 Days of Treatment, Supporting Restoration of Glucose

Insulin Resistance Was Normalized Following 14 Days of Treatment, Supporting Restoration of Glucose

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers;

Study Published in Advances in Redox Research Demonstrated Dose-Dependent Survival Improvement, Redu

Company Plans to Initiate First-in-Human Phase 1/2 Trial in 1H 2026, Anchored by a Leading U.S. Acad

Telomir Pharmaceuticals, Inc. (NASDAQ: TELO - Get Free Report) shares traded up 1.4% during trading

Transaction establishes global ownership rights of lead program and includes initial capital funding

Telomir Pharmaceuticals (NASDAQ: TELO - Get Free Report) and Jaguar Animal Health (NASDAQ: JAGX - Ge

First-in-class metal-modulating epigenetic therapy targeting iron-dependent pathways with preclinica

Iron-rescue experiments confirm tumor cell mortality is mechanistically driven, not nonspecific cyto

Cellular findings show Telomir-Zn modulates intracellular metal balance linked to oxidative stress,

Telomir Pharmaceuticals (NASDAQ: TELO - Get Free Report) is expected to be issuing its results befor

electroCore (NASDAQ: ECOR - Get Free Report) and Telomir Pharmaceuticals (NASDAQ: TELO - Get Free Re

In a TNBC animal model with limited responsiveness to chemotherapy, Telomir-1 demonstrated statistic

Telomir Pharmaceuticals, Inc. (NASDAQ: TELO - Get Free Report) was down 8.9% on Monday. The stock tr

No treatment-related adverse toxicity was observed across completed GLP studies, with consistent sys

Shares of Herbalife Ltd. (NYSE: HLF) fell sharply in today’s session following weak quarterly earni